Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005930 | axoneme | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
GO:0001534 | radial spoke | 2 | 2 |
GO:0032991 | protein-containing complex | 1 | 2 |
Related structures:
AlphaFold database: A4HTB7
Term | Name | Level | Count |
---|---|---|---|
GO:0000226 | microtubule cytoskeleton organization | 3 | 1 |
GO:0001578 | microtubule bundle formation | 4 | 1 |
GO:0003341 | cilium movement | 4 | 3 |
GO:0006996 | organelle organization | 4 | 3 |
GO:0007010 | cytoskeleton organization | 5 | 1 |
GO:0007017 | microtubule-based process | 2 | 3 |
GO:0007018 | microtubule-based movement | 3 | 3 |
GO:0009987 | cellular process | 1 | 3 |
GO:0016043 | cellular component organization | 3 | 3 |
GO:0022607 | cellular component assembly | 4 | 3 |
GO:0030030 | cell projection organization | 4 | 3 |
GO:0030031 | cell projection assembly | 5 | 3 |
GO:0035082 | axoneme assembly | 5 | 1 |
GO:0044458 | motile cilium assembly | 7 | 1 |
GO:0044782 | cilium organization | 5 | 3 |
GO:0060271 | cilium assembly | 6 | 3 |
GO:0060294 | cilium movement involved in cell motility | 5 | 3 |
GO:0070925 | organelle assembly | 5 | 3 |
GO:0071840 | cellular component organization or biogenesis | 2 | 3 |
GO:0120031 | plasma membrane bounded cell projection assembly | 6 | 3 |
GO:0120036 | plasma membrane bounded cell projection organization | 5 | 3 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 182 | 184 | PF00675 | 0.670 |
CLV_PCSK_KEX2_1 | 184 | 186 | PF00082 | 0.561 |
CLV_PCSK_PC1ET2_1 | 184 | 186 | PF00082 | 0.561 |
CLV_PCSK_SKI1_1 | 185 | 189 | PF00082 | 0.643 |
CLV_PCSK_SKI1_1 | 301 | 305 | PF00082 | 0.464 |
DOC_CKS1_1 | 125 | 130 | PF01111 | 0.633 |
DOC_MAPK_gen_1 | 183 | 194 | PF00069 | 0.488 |
DOC_MAPK_gen_1 | 34 | 42 | PF00069 | 0.483 |
DOC_PP1_SILK_1 | 129 | 134 | PF00149 | 0.426 |
DOC_USP7_MATH_1 | 152 | 156 | PF00917 | 0.713 |
DOC_USP7_MATH_1 | 229 | 233 | PF00917 | 0.604 |
DOC_USP7_MATH_1 | 66 | 70 | PF00917 | 0.475 |
DOC_USP7_UBL2_3 | 184 | 188 | PF12436 | 0.543 |
DOC_USP7_UBL2_3 | 41 | 45 | PF12436 | 0.444 |
DOC_WW_Pin1_4 | 124 | 129 | PF00397 | 0.661 |
DOC_WW_Pin1_4 | 35 | 40 | PF00397 | 0.451 |
LIG_14-3-3_CanoR_1 | 190 | 195 | PF00244 | 0.504 |
LIG_14-3-3_CanoR_1 | 212 | 216 | PF00244 | 0.412 |
LIG_14-3-3_CanoR_1 | 230 | 235 | PF00244 | 0.605 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.392 |
LIG_FHA_1 | 270 | 276 | PF00498 | 0.395 |
LIG_FHA_1 | 292 | 298 | PF00498 | 0.429 |
LIG_FHA_2 | 15 | 21 | PF00498 | 0.514 |
LIG_LIR_Apic_2 | 272 | 277 | PF02991 | 0.485 |
LIG_LIR_Apic_2 | 308 | 314 | PF02991 | 0.344 |
LIG_LIR_Gen_1 | 105 | 114 | PF02991 | 0.524 |
LIG_LIR_Gen_1 | 246 | 254 | PF02991 | 0.398 |
LIG_LIR_Gen_1 | 78 | 85 | PF02991 | 0.548 |
LIG_LIR_Nem_3 | 69 | 73 | PF02991 | 0.393 |
LIG_LIR_Nem_3 | 78 | 82 | PF02991 | 0.405 |
LIG_PDZ_Class_2 | 332 | 337 | PF00595 | 0.436 |
LIG_Pex14_1 | 287 | 291 | PF04695 | 0.373 |
LIG_Pex14_2 | 331 | 335 | PF04695 | 0.449 |
LIG_PTB_Apo_2 | 2 | 9 | PF02174 | 0.527 |
LIG_PTB_Apo_2 | 299 | 306 | PF02174 | 0.359 |
LIG_PTB_Apo_2 | 58 | 65 | PF02174 | 0.503 |
LIG_PTB_Phospho_1 | 2 | 8 | PF10480 | 0.534 |
LIG_PTB_Phospho_1 | 299 | 305 | PF10480 | 0.395 |
LIG_SH2_CRK | 100 | 104 | PF00017 | 0.520 |
LIG_SH2_CRK | 323 | 327 | PF00017 | 0.454 |
LIG_SH2_STAP1 | 106 | 110 | PF00017 | 0.526 |
LIG_SH2_STAT3 | 219 | 222 | PF00017 | 0.464 |
LIG_SH2_STAT5 | 219 | 222 | PF00017 | 0.407 |
LIG_SH2_STAT5 | 248 | 251 | PF00017 | 0.375 |
LIG_SH2_STAT5 | 274 | 277 | PF00017 | 0.478 |
LIG_SH2_STAT5 | 323 | 326 | PF00017 | 0.382 |
LIG_SH2_STAT5 | 8 | 11 | PF00017 | 0.421 |
LIG_SH3_3 | 120 | 126 | PF00018 | 0.592 |
LIG_SH3_3 | 176 | 182 | PF00018 | 0.676 |
LIG_SH3_5 | 270 | 274 | PF00018 | 0.506 |
LIG_SUMO_SIM_par_1 | 190 | 196 | PF11976 | 0.429 |
MOD_CAAXbox | 334 | 337 | PF01239 | 0.452 |
MOD_CDK_SPxK_1 | 35 | 41 | PF00069 | 0.465 |
MOD_CK1_1 | 14 | 20 | PF00069 | 0.475 |
MOD_CK1_1 | 69 | 75 | PF00069 | 0.400 |
MOD_CK1_1 | 83 | 89 | PF00069 | 0.465 |
MOD_CK2_1 | 14 | 20 | PF00069 | 0.390 |
MOD_CK2_1 | 190 | 196 | PF00069 | 0.479 |
MOD_GSK3_1 | 143 | 150 | PF00069 | 0.586 |
MOD_N-GLC_1 | 230 | 235 | PF02516 | 0.527 |
MOD_N-GLC_1 | 291 | 296 | PF02516 | 0.538 |
MOD_NEK2_1 | 11 | 16 | PF00069 | 0.536 |
MOD_NEK2_1 | 24 | 29 | PF00069 | 0.224 |
MOD_NEK2_2 | 211 | 216 | PF00069 | 0.452 |
MOD_NEK2_2 | 285 | 290 | PF00069 | 0.494 |
MOD_NEK2_2 | 305 | 310 | PF00069 | 0.154 |
MOD_NEK2_2 | 66 | 71 | PF00069 | 0.471 |
MOD_PIKK_1 | 29 | 35 | PF00454 | 0.524 |
MOD_PK_1 | 190 | 196 | PF00069 | 0.514 |
MOD_PKA_1 | 243 | 249 | PF00069 | 0.510 |
MOD_PKA_2 | 211 | 217 | PF00069 | 0.413 |
MOD_PKA_2 | 229 | 235 | PF00069 | 0.601 |
MOD_Plk_1 | 19 | 25 | PF00069 | 0.470 |
MOD_Plk_1 | 230 | 236 | PF00069 | 0.557 |
MOD_Plk_2-3 | 147 | 153 | PF00069 | 0.712 |
MOD_Plk_4 | 305 | 311 | PF00069 | 0.358 |
MOD_Plk_4 | 66 | 72 | PF00069 | 0.434 |
MOD_ProDKin_1 | 124 | 130 | PF00069 | 0.653 |
MOD_ProDKin_1 | 35 | 41 | PF00069 | 0.450 |
TRG_DiLeu_BaEn_3 | 257 | 263 | PF01217 | 0.526 |
TRG_DiLeu_BaEn_4 | 87 | 93 | PF01217 | 0.559 |
TRG_DiLeu_BaLyEn_6 | 26 | 31 | PF01217 | 0.405 |
TRG_DiLeu_BaLyEn_6 | 7 | 12 | PF01217 | 0.440 |
TRG_ENDOCYTIC_2 | 100 | 103 | PF00928 | 0.508 |
TRG_ENDOCYTIC_2 | 106 | 109 | PF00928 | 0.546 |
TRG_ENDOCYTIC_2 | 248 | 251 | PF00928 | 0.369 |
TRG_ENDOCYTIC_2 | 8 | 11 | PF00928 | 0.501 |
TRG_ER_diArg_1 | 182 | 185 | PF00400 | 0.691 |
TRG_ER_diArg_1 | 259 | 262 | PF00400 | 0.447 |
TRG_NLS_MonoExtN_4 | 180 | 187 | PF00514 | 0.568 |
TRG_Pf-PMV_PEXEL_1 | 301 | 306 | PF00026 | 0.471 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IL99 | Leptomonas seymouri | 72% | 99% |
A0A0S4J8G1 | Bodo saltans | 39% | 100% |
A0A1X0NQ76 | Trypanosomatidae | 50% | 100% |
A0A3Q8IKD9 | Leishmania donovani | 24% | 100% |
A0A3R7MSU5 | Trypanosoma rangeli | 50% | 100% |
A0A3S7WQ16 | Leishmania donovani | 97% | 100% |
A4H541 | Leishmania braziliensis | 85% | 99% |
C9ZUK2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 49% | 100% |
D0A660 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 28% | 100% |
E9AHR8 | Leishmania infantum | 24% | 100% |
E9ALB0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 98% |
E9B489 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 24% | 100% |
Q4Q3T7 | Leishmania major | 24% | 100% |
Q4QIJ4 | Leishmania major | 97% | 99% |
Q5TYW6 | Danio rerio | 26% | 100% |
Q9D9V4 | Mus musculus | 24% | 100% |
Q9H1X1 | Homo sapiens | 24% | 100% |